May 2019

May 17th, 2019

NIH administers first clinical trial treatment for GM1 created by Auburn, UMass

Milestone marks the first patient with GM1 gangliosidosis treated with gene therapy The first clinical trial of a gene therapy treatment created through a research alliance between Auburn University and the University of Massachusetts has been administered in a child at the National Institutes of Health, or NIH, in Bethesda, Maryland. The NIH clinical trial […]

February 2019

Feb 22nd, 2019

Auburn University senior is on a mission for a cure for GM1

When Auburn University senior Cassie Bebout was 6 years old, her 9-year-old brother Jake died from GM1, a rare genetic disease with no cure. Cassie’s life was changed forever. The senior molecular biology major, who will earn her bachelor’s degree in May, has devoted her college career to helping find a possible cure for the […]